ENS 43073: Difference between revisions
Jump to navigation
Jump to search
StriderTol (talk | contribs) (Created page by program invented by Mark Hawes) |
StriderTol (talk | contribs) (Created page by program invented by StriderTol) |
||
| Line 16: | Line 16: | ||
| event date = 12/28/2006 07:30 EST | | event date = 12/28/2006 07:30 EST | ||
| last update date = 01/04/2007 | | last update date = 01/04/2007 | ||
| title = Agreement State Report - Failure | | title = Agreement State Report - Failure of Source to Retract Into Afterloader Unit | ||
| event text = The State provided the following information via facsimile: | | event text = The State provided the following information via facsimile: | ||
Prior to a scheduled patient treatment, the RSO at Methodist Medical Center was performing QA testing on the Nucletron-Oldelft Corp. Model microSelection-HDR remote afterloading device. The device utilizes a sealed source containing 10 curies of Iridium-192 to be used for treatment of cancer in humans. The sealed source would not retract when the RSO tried the emergency retraction button at the control console. Following the emergency procedures, the RSO manually retracted the sealed source into the HDR afterloader unit. The RSO estimated it took three seconds to return the sealed source to its shielded position. Nucletron Corp. was immediately notified of the malfunction by the RSO. Nucletron Corp. called DRH to request reciprocal recognition of its Maryland license and an authorized service person arrived at the licensee's facility on 12/28/06. The circuit board was found to be faulty and was repaired. After repair, the required safety functions of the system were tested and found to be functioning as designed. The licensee will complete a written report and submit to the State. | Prior to a scheduled patient treatment, the RSO at Methodist Medical Center was performing QA testing on the Nucletron-Oldelft Corp. Model microSelection-HDR remote afterloading device. The device utilizes a sealed source containing 10 curies of Iridium-192 to be used for treatment of cancer in humans. The sealed source would not retract when the RSO tried the emergency retraction button at the control console. Following the emergency procedures, the RSO manually retracted the sealed source into the HDR afterloader unit. The RSO estimated it took three seconds to return the sealed source to its shielded position. Nucletron Corp. was immediately notified of the malfunction by the RSO. Nucletron Corp. called DRH to request reciprocal recognition of its Maryland license and an authorized service person arrived at the licensee's facility on 12/28/06. The circuit board was found to be faulty and was repaired. After repair, the required safety functions of the system were tested and found to be functioning as designed. The licensee will complete a written report and submit to the State. | ||
Latest revision as of 21:17, 1 March 2018
| Where | |
|---|---|
| Methodist Medical Center Of Oak Ridge Oak Ridge, Tennessee (NRC Region 1) | |
| License number: | R-01083 |
| Organization: | Tennessee Div Of Rad Health |
| Reporting | |
| Agreement State | |
| Time - Person (Reporting Time:+166.28 h6.928 days <br />0.99 weeks <br />0.228 months <br />) | |
| Opened: | Billy Freeman 10:47 Jan 4, 2007 |
| NRC Officer: | Jason Kozal |
| Last Updated: | Jan 4, 2007 |
| 43073 - NRC Website | |